CoreySCutlerMD

Clinical Trials

• Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Start of enrollment: 2004 Jan 01

  Completed

  Phase 3

• Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease Start of enrollment: 2004 Jan 01

  Completed

  Phase 1, Phase 2

• Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation Start of enrollment: 2003 Nov 01

  Completed

  Phase 2

• Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation Start of enrollment: 2002 Jul 01

  Completed

  Phase 2

• Rituximab for Prevention of Chronic GVHD Start of enrollment: 2006 Sep 01

  Completed

  Phase 1, Phase 2

• Campath in Chronic GVHD Start of enrollment: 2007 Jul 01

  Completed

  Phase 1

• Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation Start of enrollment: 2007 Oct 01

  Terminated

  Phase 2

• Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies. Start of enrollment: 2011 Jan 01

  Completed

  Phase 1

• Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01

  Completed

  Phase 2, Phase 3

• Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease Start of enrollment: 2010 Oct 01

  Terminated

  Phase 2

• Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease Start of enrollment: 2011 Mar 01

  Completed

  Phase 2

• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01

  Recruiting

• Reduced Intensity Double Umbilical Cord Blood Transplantation Start of enrollment: 2011 Dec 01

  Completed

  Phase 2

• Brentuximab Vedotin for Steroid Refractory GvHD Start of enrollment: 2012 Jul 01

  Completed

  Phase 1

• The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies. Start of enrollment: 2012 Jul 01

  Terminated

  Phase 2

• Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation Start of enrollment: 2012 Feb 01

  Recruiting

  Phase 2

• Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102) Start of enrollment: 2013 Dec 16

  Completed

  Phase 2

• Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCT Start of enrollment: 2014 Apr 01

  Terminated

  Phase 1

• An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease Start of enrollment: 2014 Jul 01

  Terminated

  Phase 2

• Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD Start of enrollment: 2015 Jan 01

  Completed

  Phase 2

• Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study Start of enrollment: 2020 Jun 29

  Recruiting

• Join now to see all